The next era of medicine is electric.

Your cells talk to one another in electrical signals. Bioelectronic medicine speaks that language directly. Stimcore is building the non-invasive platform for it: sleep is first, sports is next, and there is more we can’t show yet.

Scroll
$62.8B

Projected global bioelectronics market by 2034.

Dataintelo ↗

“I think we’re coming to a tipping point when patients will demand [access to bioelectronic medicine] because it can be done safely and it’s much more cost effective.”

Kevin Tracey, MD, Feinstein Institutes for Medical Research · AAMC
The science

Your body speaks in electricity. Bioelectric signals are how cells talk to one another, and they shape how the body heals, feels, recovers, and performs at every level.

  • CellSignals tell cells when to repair, grow or calm inflammation.
  • TissueChange the signal, and the tissue responds.
  • BodyFrom one cell to the whole system, performance follows.
3in4

U.S. adults have at least one chronic condition.

50%+

have two or more.

CDC ↗

Modern medicine manages symptoms. We’re going after the root cause.

Medicine today
  • A pill for every ill
  • One-size-fits-all treatment
  • The problem is managed, never solved
Stimcore
  • The body’s own signals, used to restore function
  • Precise, personalized care
  • Treatment aimed at the cause, not the symptom
The platform

One platform. Many signals.

Stimcore is built as a platform, not a single product. Every signal is generated digitally, so it can be programmed, repeated and refined, and each treatment site is controlled independently. Because every application runs on the same hardware and software foundation, progress in one program is designed to benefit the others. Our first program is in sleep. A second, in sports therapy, is in development.

4 signals · 1 platformIllustrative
Development partner

Engineered with StarFish Medical.

Stimcore has partnered with StarFish Medical to develop its devices. Founded in 1999 and headquartered in Victoria, British Columbia, StarFish is a full-service medical device design, development and manufacturing firm with roughly 230 staff and offices in Canada and California. The company has contributed to more than 1,000 medical device programs and operates under an ISO 13485 quality management system. StarFish’s engineering, quality and regulatory teams support Stimcore’s development work, from design through the regulatory process.

StarFish Medical team members reviewing device prototypes
StarFish Medical engineer working at an electronics lab bench
StarFish Medical clinical specialist testing an infusion component
The verticals

One platform. Many markets.

Coming soon

Stimcore Sleep

A non-invasive, in-office treatment to improve sleep, with wearable devices to follow.

Sports photo to come
Coming soon

Stimcore Sports

Devices for professional and personal use in athletic performance and recovery.

Stimcore

The platform doesn’t stop at two. The next vertical is under wraps for now. Investors can ask us about it.

In development

McKinsey positions bioelectronics as a “pillar of medical treatment” in the future, with significant commercial and clinical impact over the next 20 years.

McKinsey & CompanyMcKinsey ↗
Leadership

Built by people who’ve done it before.

John Guidon

John Guidon

CEO and President

John Guidon brings a rare combination of deep engineering expertise and proven entrepreneurial execution to his role as CEO. A trained electrical engineer, John has founded and scaled multiple technology companies with successful exits totaling $1.5B, including ventures in miniaturized medical electronics. He is the principal architect of Stimcore’s proprietary signal delivery system and leads the company’s overall strategic and operational direction.

Dr. Blair Bittner

Dr. Blair Bittner, DDS

Founder and Chief Development Officer

Dr. Blair Bittner is the Founder of Stimcore and a practicing clinician with 25+ years of experience at the intersection of sleep medicine, dentistry, and bioelectric technology applications. Dr. Bittner’s vision for a wearable treatment system is the foundation of the Company. Dr. Bittner also serves as Founder of Convergent Sleep™ and provides the clinical vision that anchors both organizations.

David Werner

David Werner

Title to come

David Werner brings a powerhouse combination of aggressive SaaS disruption and a proven track record of value creation to the team. An experienced entrepreneur and investor, David has systematically challenged legacy industry models by architecting high-growth platforms that lead to multi-million dollar liquidity events. He specializes in turning complex emerging technologies into dominant, hyper-scalable enterprises with a clear path to monetization. In his role, David drives the company’s commercial scaling, platform growth strategies, and overarching market expansion efforts to maximize investor returns.

Dr. Joshua Berka

Dr. Joshua Berka, NMD

Scientific and Medical Consultant

Dr. Joshua Berka serves as Scientific and Medical Consultant, contributing deep expertise in bioelectricity and functional medicine to Stimcore’s clinical and product development process. Berka is a well-known expert in the field of bioelectric therapeutics and brings a rigorous scientific framework to the company’s treatment protocols and evidence strategy.

Let’s talk

Stay ahead of the shift.

Investors, clinicians and partners can request information here, or contact us directly. We’ll share more as the platform is revealed.

Investor relationsShawn TooheyShawn@stimcoremd.com · (760) 238-2109
I am a

This site is for information only and is not an offer to sell, or a solicitation of an offer to buy, any security.